ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 171 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $35 | +59.1% | 35,400 | +126.9% | 0.00% | – |
| Q2 2023 | $22 | -54.2% | 15,600 | -47.6% | 0.00% | – |
| Q1 2023 | $48 | -73.0% | 29,764 | +3.9% | 0.00% | – |
| Q4 2022 | $178 | -99.9% | 28,642 | +5.2% | 0.00% | – |
| Q3 2022 | $183,000 | +61.9% | 27,227 | +52.8% | 0.00% | – |
| Q2 2022 | $113,000 | +43.0% | 17,819 | +4.3% | 0.00% | – |
| Q1 2022 | $79,000 | -70.8% | 17,091 | -24.1% | 0.00% | – |
| Q3 2021 | $271,000 | -27.0% | 22,522 | +28.5% | 0.00% | – |
| Q2 2021 | $371,000 | -22.4% | 17,522 | +2.8% | 0.00% | – |
| Q1 2021 | $478,000 | +82.4% | 17,042 | +69.3% | 0.00% | – |
| Q4 2020 | $262,000 | -46.4% | 10,066 | -23.5% | 0.00% | – |
| Q3 2020 | $489,000 | -94.9% | 13,166 | -92.9% | 0.00% | -100.0% |
| Q2 2020 | $9,509,000 | +50.2% | 185,327 | -7.7% | 0.00% | 0.0% |
| Q1 2020 | $6,333,000 | +144.7% | 200,842 | +362.8% | 0.00% | – |
| Q4 2019 | $2,588,000 | -79.3% | 43,396 | -87.3% | 0.00% | -100.0% |
| Q3 2019 | $12,502,000 | -20.0% | 341,027 | +1.5% | 0.00% | 0.0% |
| Q2 2019 | $15,627,000 | -16.4% | 335,912 | -27.8% | 0.00% | -33.3% |
| Q1 2019 | $18,692,000 | +37.0% | 465,557 | +56.9% | 0.00% | +50.0% |
| Q4 2018 | $13,647,000 | +1.5% | 296,673 | -2.1% | 0.00% | 0.0% |
| Q3 2018 | $13,446,000 | +13.3% | 303,036 | +0.0% | 0.00% | 0.0% |
| Q2 2018 | $11,871,000 | -44.3% | 302,903 | +2.7% | 0.00% | -33.3% |
| Q1 2018 | $21,326,000 | +70.4% | 294,844 | +55.1% | 0.00% | +50.0% |
| Q4 2017 | $12,515,000 | +218.6% | 190,087 | +142.6% | 0.00% | +100.0% |
| Q3 2017 | $3,928,000 | +4.1% | 78,364 | -3.9% | 0.00% | 0.0% |
| Q2 2017 | $3,774,000 | +13.6% | 81,547 | -13.4% | 0.00% | 0.0% |
| Q1 2017 | $3,323,000 | +171.9% | 94,117 | -3.6% | 0.00% | – |
| Q4 2016 | $1,222,000 | -11.8% | 97,617 | -2.4% | 0.00% | – |
| Q3 2016 | $1,386,000 | +46.0% | 100,060 | +4.2% | 0.00% | – |
| Q2 2016 | $949,000 | -41.9% | 96,040 | -0.6% | 0.00% | – |
| Q1 2016 | $1,633,000 | -24.0% | 96,585 | 0.0% | 0.00% | – |
| Q4 2015 | $2,150,000 | +2.1% | 96,585 | +8.2% | 0.00% | – |
| Q3 2015 | $2,106,000 | -71.1% | 89,272 | 0.0% | 0.00% | -100.0% |
| Q2 2015 | $7,299,000 | -36.8% | 89,272 | -28.4% | 0.00% | 0.0% |
| Q1 2015 | $11,542,000 | – | 124,644 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 2,679,835 | $69,675,000 | 19.39% |
| Endurant Capital Management LP | 207,293 | $5,390,000 | 1.94% |
| Bellevue Group AG | 5,138,451 | $133,599,000 | 1.53% |
| Rhenman & Partners Asset Management AB | 592,225 | $15,398,000 | 1.26% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,562,869 | $40,635,000 | 0.93% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 31,434 | $817,000 | 0.62% |
| WASATCH ADVISORS LP | 3,998,010 | $103,949,000 | 0.51% |
| HAMILTON LANE ADVISORS LLC | 46,181 | $1,201,000 | 0.45% |
| Boxer Capital, LLC | 500,000 | $13,000,000 | 0.42% |
| DCF Advisers, LLC | 38,500 | $1,001,000 | 0.41% |